Literature DB >> 8379530

Endocrine aspects of exocrine cancer of the pancreas. Their patterns and suggested biologic significance.

P M Pour1, J Permert, M Mogaki, H Fujii, K Kazakoff.   

Abstract

Nine human exocrine pancreatic adenocarcinomas were examined by serial sectioning and double- and triple-labeled immunohistochemical techniques with antibodies against chromogranin A, insulin, islet amyloid polypeptide, glucagon, somatostatin, pancreatic polypeptide, serotonin, pancreastatin, and neuron-specific enolase. The results were correlated with the stage of the disease, histologic characteristics of the tumors, and survival of the patients. Cells immunoreactive with most or all of the antibodies were found in all nine cases. Abnormal co-location of some hormones in the same cell and the lack of normal co-location of other hormones were found. Endocrine cells also were identified in the invasive regions of the cancer, including perineural spaces. Abnormality in the production and release of the peptide was indicated not only in the endocrine cells of exocrine cancer, but also in the islets near the cancer. Patients whose cancer contained many endocrine cells seemed to survive longer than those with tumors containing fewer endocrine cells. The overall data suggested that the observed abnormalities may contribute to the impaired glucose tolerance found in six of these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379530     DOI: 10.1093/ajcp/100.3.223

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  16 in total

1.  Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.

Authors:  F Wang; J Larsson; A Abdiu; T Gasslander; P Westermark; T E Adrian; J Permert
Journal:  Int J Pancreatol       Date:  1997-04

2.  Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease.

Authors:  Mark Kidd; Irvin M Modlin; Shrikant M Mane; Robert L Camp; Michael D Shapiro
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  One thousand faces of Langerhans islets.

Authors:  P M Pour; B M Schmied
Journal:  Int J Pancreatol       Date:  1999-06

Review 4.  The role of Langerhans islets in exocrine pancreatic cancer.

Authors:  P M Pour
Journal:  Int J Pancreatol       Date:  1995-06

5.  Endocrine cells in hepatobiliary cystadenomas and cystadenocarcinomas.

Authors:  T Terada; Y Kitamura; T Ohta; Y Nakanuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

6.  Experimental evidence for the origin of ductal-type adenocarcinoma from the islets of Langerhans.

Authors:  P M Pour; L Weide; G Liu; K Kazakoff; M Scheetz; I Toshkov; Y Ikematsu; M A Fienhold; W Sanger
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

7.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

8.  Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: characterization of the endocrine cells.

Authors:  N Ohike; A Jürgensen; M Pipeleers-Marichal; G Klöppel
Journal:  Virchows Arch       Date:  2003-02-06       Impact factor: 4.064

Review 9.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

10.  Neoplastic endocrine differentiation of pancreatic ductal adenocarcinoma in a metastatic lymph node: report of a case.

Authors:  Tomotaka Akatsu; Kaori Kameyama; Yuki Nogami; Shigeyuki Kawachi; Masaki Kitajima; Yuko Kitagawa
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.